Catalent Inc (CTLT)
60.33
+0.04
(+0.07%)
USD |
NYSE |
Sep 27, 16:00
60.31
-0.02
(-0.03%)
Pre-Market: 20:00
Catalent SG&A Expense (TTM): 935.00M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 935.00M |
March 31, 2024 | 886.00M |
December 31, 2023 | 862.00M |
September 30, 2023 | 838.00M |
June 30, 2023 | 829.00M |
March 31, 2023 | 838.00M |
December 31, 2022 | 855.00M |
September 30, 2022 | 857.00M |
June 30, 2022 | 844.00M |
March 31, 2022 | 802.00M |
December 31, 2021 | 768.00M |
September 30, 2021 | 705.00M |
June 30, 2021 | 687.00M |
March 31, 2021 | 660.10M |
December 31, 2020 | 623.20M |
September 30, 2020 | 599.20M |
June 30, 2020 | 577.00M |
March 31, 2020 | 563.30M |
December 31, 2019 | 557.10M |
September 30, 2019 | 539.30M |
June 30, 2019 | 512.00M |
March 31, 2019 | 493.50M |
December 31, 2018 | 481.20M |
Date | Value |
---|---|
September 30, 2018 | 472.80M |
June 30, 2018 | 464.80M |
March 31, 2018 | 447.20M |
December 31, 2017 | 430.50M |
September 30, 2017 | 411.90M |
June 30, 2017 | 402.60M |
March 31, 2017 | 384.80M |
December 31, 2016 | 377.30M |
September 30, 2016 | 374.10M |
June 30, 2016 | 358.20M |
March 31, 2016 | 355.60M |
December 31, 2015 | 343.10M |
September 30, 2015 | 338.20M |
June 30, 2015 | 337.30M |
March 31, 2015 | 329.00M |
December 31, 2014 | 335.70M |
September 30, 2014 | 335.10M |
June 30, 2014 | 334.80M |
March 31, 2014 | 345.10M |
December 31, 2013 | 341.20M |
September 30, 2013 | 339.90M |
June 30, 2013 | 340.60M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
539.30M
Minimum
Sep 2019
935.00M
Maximum
Jun 2024
741.26M
Average
785.00M
Median
SG&A Expense (TTM) Benchmarks
United Therapeutics Corp | 581.80M |
The Cooper Companies Inc | 1.530B |
Johnson & Johnson | 21.15B |
Merck & Co Inc | 10.54B |
BioCardia Inc | 3.965M |